Selected research
Market Structure
Global Lipid Nanoparticle Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lipid Nanoparticle Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lipid Nanoparticle Solutions include Merck, Cytiva, GenScript, Creative Biolabs, WuXi STA, Carcell, Croda International, Detai Biotechnology and Waters, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Lipid Nanoparticle Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lipid Nanoparticle Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lipid Nanoparticle Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lipid Nanoparticle Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.
Lipid Nanoparticle Solutions Segment by Company
Merck
Cytiva
GenScript
Creative Biolabs
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Exelead
Nippon Fine Chemical
Lipoid
Lipid Nanoparticle Solutions Segment by Type
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Lipid Nanoparticle Solutions Segment by Application
Gene Therapy
Vaccine Development
Cancer Treatment
Lipid Nanoparticle Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lipid Nanoparticle Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Nanoparticle Solutions industry.
Chapter 3: Detailed analysis of Lipid Nanoparticle Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle Solutionsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Cationic Lipid-Nucleic Acid Complexes
Applications
- Gene Therapy
- Vaccine Development
- Cancer Treatment
Companies covered
- Merck
- Cytiva
- GenScript
- Creative Biolabs
- WuXi STA
- Carcell
- Croda International
- Detai Biotechnology
- Waters
- MicroNano Biologics
- Precigenome
- Evonik
- Avanti Polar Lipids
- Genevant Sciences
- Exelead
- Nippon Fine Chemical
- Lipoid
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Lipid Nanoparticle Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Solid Lipid Nanoparticles
- 1.2.3 Nanostructured Lipid Carriers
- 1.2.4 Cationic Lipid-Nucleic Acid Complexes
- 1.3 Market Analysis by Application
- 1.3.1 Global Lipid Nanoparticle Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gene Therapy
- 1.3.3 Vaccine Development
- 1.3.4 Cancer Treatment
- 1.4 Global Market Growth Prospects
- 1.5 Global Lipid Nanoparticle Solutions Growth Trends by Region
- 1.5.1 Global Lipid Nanoparticle Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Lipid Nanoparticle Solutions Market Size by Region (2021-2026)
- 1.5.3 Lipid Nanoparticle Solutions Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Lipid Nanoparticle Solutions Market Dynamics
- 2.1 Lipid Nanoparticle Solutions Industry Trends
- 2.2 Lipid Nanoparticle Solutions Industry Drivers
- 2.3 Lipid Nanoparticle Solutions Industry Opportunities and Challenges
- 2.4 Lipid Nanoparticle Solutions Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Lipid Nanoparticle Solutions Revenue by Company (2021-2026)
- 3.2 Global Lipid Nanoparticle Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Lipid Nanoparticle Solutions Key Company Head office and Area Served
- 3.4 Global Lipid Nanoparticle Solutions Company, Product Type & Application
- 3.5 Global Lipid Nanoparticle Solutions Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Lipid Nanoparticle Solutions Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Lipid Nanoparticle Solutions Players Market Share by Revenue in 2025
- 3.6.3 2025 Lipid Nanoparticle Solutions Tier 1, Tier 2, and Tier 3
4 Lipid Nanoparticle Solutions Market by Type
- 4.1 Global Lipid Nanoparticle Solutions Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Lipid Nanoparticle Solutions Market Size by Type (2021-2032)
- 4.3 Global Lipid Nanoparticle Solutions Market Size Share by Type (2021-2032)
5 Lipid Nanoparticle Solutions Market by Application
- 5.1 Global Lipid Nanoparticle Solutions Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Lipid Nanoparticle Solutions Market Size by Application (2021-2032)
- 5.3 Global Lipid Nanoparticle Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck Lipid Nanoparticle Solutions Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Cytiva
- 6.2.1 Cytiva Company Information
- 6.2.2 Cytiva Business Overview
- 6.2.3 Cytiva Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Cytiva Lipid Nanoparticle Solutions Product Portfolio
- 6.2.5 Cytiva Recent Developments
- 6.3 GenScript
- 6.3.1 GenScript Company Information
- 6.3.2 GenScript Business Overview
- 6.3.3 GenScript Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GenScript Lipid Nanoparticle Solutions Product Portfolio
- 6.3.5 GenScript Recent Developments
- 6.4 Creative Biolabs
- 6.4.1 Creative Biolabs Company Information
- 6.4.2 Creative Biolabs Business Overview
- 6.4.3 Creative Biolabs Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio
- 6.4.5 Creative Biolabs Recent Developments
- 6.5 WuXi STA
- 6.5.1 WuXi STA Company Information
- 6.5.2 WuXi STA Business Overview
- 6.5.3 WuXi STA Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 WuXi STA Lipid Nanoparticle Solutions Product Portfolio
- 6.5.5 WuXi STA Recent Developments
- 6.6 Carcell
- 6.6.1 Carcell Company Information
- 6.6.2 Carcell Business Overview
- 6.6.3 Carcell Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Carcell Lipid Nanoparticle Solutions Product Portfolio
- 6.6.5 Carcell Recent Developments
- 6.7 Croda International
- 6.7.1 Croda International Company Information
- 6.7.2 Croda International Business Overview
- 6.7.3 Croda International Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Croda International Lipid Nanoparticle Solutions Product Portfolio
- 6.7.5 Croda International Recent Developments
- 6.8 Detai Biotechnology
- 6.8.1 Detai Biotechnology Company Information
- 6.8.2 Detai Biotechnology Business Overview
- 6.8.3 Detai Biotechnology Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio
- 6.8.5 Detai Biotechnology Recent Developments
- 6.9 Waters
- 6.9.1 Waters Company Information
- 6.9.2 Waters Business Overview
- 6.9.3 Waters Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Waters Lipid Nanoparticle Solutions Product Portfolio
- 6.9.5 Waters Recent Developments
- 6.10 MicroNano Biologics
- 6.10.1 MicroNano Biologics Company Information
- 6.10.2 MicroNano Biologics Business Overview
- 6.10.3 MicroNano Biologics Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio
- 6.10.5 MicroNano Biologics Recent Developments
- 6.11 Precigenome
- 6.11.1 Precigenome Company Information
- 6.11.2 Precigenome Business Overview
- 6.11.3 Precigenome Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Precigenome Lipid Nanoparticle Solutions Product Portfolio
- 6.11.5 Precigenome Recent Developments
- 6.12 Evonik
- 6.12.1 Evonik Company Information
- 6.12.2 Evonik Business Overview
- 6.12.3 Evonik Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Evonik Lipid Nanoparticle Solutions Product Portfolio
- 6.12.5 Evonik Recent Developments
- 6.13 Avanti Polar Lipids
- 6.13.1 Avanti Polar Lipids Company Information
- 6.13.2 Avanti Polar Lipids Business Overview
- 6.13.3 Avanti Polar Lipids Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio
- 6.13.5 Avanti Polar Lipids Recent Developments
- 6.14 Genevant Sciences
- 6.14.1 Genevant Sciences Company Information
- 6.14.2 Genevant Sciences Business Overview
- 6.14.3 Genevant Sciences Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio
- 6.14.5 Genevant Sciences Recent Developments
- 6.15 Exelead
- 6.15.1 Exelead Company Information
- 6.15.2 Exelead Business Overview
- 6.15.3 Exelead Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Exelead Lipid Nanoparticle Solutions Product Portfolio
- 6.15.5 Exelead Recent Developments
- 6.16 Nippon Fine Chemical
- 6.16.1 Nippon Fine Chemical Company Information
- 6.16.2 Nippon Fine Chemical Business Overview
- 6.16.3 Nippon Fine Chemical Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio
- 6.16.5 Nippon Fine Chemical Recent Developments
- 6.17 Lipoid
- 6.17.1 Lipoid Company Information
- 6.17.2 Lipoid Business Overview
- 6.17.3 Lipoid Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Lipoid Lipid Nanoparticle Solutions Product Portfolio
- 6.17.5 Lipoid Recent Developments
7 North America
- 7.1 North America Lipid Nanoparticle Solutions Market Size (2021-2032)
- 7.2 North America Lipid Nanoparticle Solutions Market Size by Type
- 7.2.1 North America Lipid Nanoparticle Solutions Market Size by Type (2021-2026)
- 7.2.2 North America Lipid Nanoparticle Solutions Market Size by Type (2027-2032)
- 7.2.3 North America Lipid Nanoparticle Solutions Market Share by Type (2021-2032)
- 7.3 North America Lipid Nanoparticle Solutions Market Size by Application
- 7.3.1 North America Lipid Nanoparticle Solutions Market Size by Application (2021-2026)
- 7.3.2 North America Lipid Nanoparticle Solutions Market Size by Application (2027-2032)
- 7.3.3 North America Lipid Nanoparticle Solutions Market Share by Application (2021-2032)
- 7.4 North America Lipid Nanoparticle Solutions Market Size by Country
- 7.4.1 North America Lipid Nanoparticle Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
- 7.4.3 North America Lipid Nanoparticle Solutions Market Size by Country (2027-2032)
- 7.4.4 North America Lipid Nanoparticle Solutions Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Lipid Nanoparticle Solutions Market Size (2021-2032)
- 8.2 Europe Lipid Nanoparticle Solutions Market Size by Type
- 8.2.1 Europe Lipid Nanoparticle Solutions Market Size by Type (2021-2026)
- 8.2.2 Europe Lipid Nanoparticle Solutions Market Size by Type (2027-2032)
- 8.2.3 Europe Lipid Nanoparticle Solutions Market Share by Type (2021-2032)
- 8.3 Europe Lipid Nanoparticle Solutions Market Size by Application
- 8.3.1 Europe Lipid Nanoparticle Solutions Market Size by Application (2021-2026)
- 8.3.2 Europe Lipid Nanoparticle Solutions Market Size by Application (2027-2032)
- 8.3.3 Europe Lipid Nanoparticle Solutions Market Share by Application (2021-2032)
- 8.4 Europe Lipid Nanoparticle Solutions Market Size by Country
- 8.4.1 Europe Lipid Nanoparticle Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
- 8.4.3 Europe Lipid Nanoparticle Solutions Market Size by Country (2027-2032)
- 8.4.4 Europe Lipid Nanoparticle Solutions Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Lipid Nanoparticle Solutions Market Size (2021-2032)
- 9.2 China Lipid Nanoparticle Solutions Market Size by Type
- 9.2.1 China Lipid Nanoparticle Solutions Market Size by Type (2021-2026)
- 9.2.2 China Lipid Nanoparticle Solutions Market Size by Type (2027-2032)
- 9.2.3 China Lipid Nanoparticle Solutions Market Share by Type (2021-2032)
- 9.3 China Lipid Nanoparticle Solutions Market Size by Application
- 9.3.1 China Lipid Nanoparticle Solutions Market Size by Application (2021-2026)
- 9.3.2 China Lipid Nanoparticle Solutions Market Size by Application (2027-2032)
- 9.3.3 China Lipid Nanoparticle Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Lipid Nanoparticle Solutions Market Size (2021-2032)
- 10.2 Asia Lipid Nanoparticle Solutions Market Size by Type
- 10.2.1 Asia Lipid Nanoparticle Solutions Market Size by Type (2021-2026)
- 10.2.2 Asia Lipid Nanoparticle Solutions Market Size by Type (2027-2032)
- 10.2.3 Asia Lipid Nanoparticle Solutions Market Share by Type (2021-2032)
- 10.3 Asia Lipid Nanoparticle Solutions Market Size by Application
- 10.3.1 Asia Lipid Nanoparticle Solutions Market Size by Application (2021-2026)
- 10.3.2 Asia Lipid Nanoparticle Solutions Market Size by Application (2027-2032)
- 10.3.3 Asia Lipid Nanoparticle Solutions Market Share by Application (2021-2032)
- 10.4 Asia Lipid Nanoparticle Solutions Market Size by Country
- 10.4.1 Asia Lipid Nanoparticle Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
- 10.4.3 Asia Lipid Nanoparticle Solutions Market Size by Country (2027-2032)
- 10.4.4 Asia Lipid Nanoparticle Solutions Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Type
- 11.2.1 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Application
- 11.3.1 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country
- 11.4.1 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Lipid Nanoparticle Solutions Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst